Testing effectiveness (Phase 2)Study completedNCT02156791
What this trial is testing
Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM
Who this might be right for
Hay Fever
BioTech Tools S.A. 61
Showing 20 of 207 results